← back to search

Xavier Delavenne

Université Claude Bernard Lyon 1 · FR
🔎 Find collaborators in Cardiology and Cardiovascular Medicine · Internal Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research focused on ATP-binding cassette transporter and Abcg2, with related work in Tranexamic acid, Efflux, Pharmacology. Notable publications include 'Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients', 'Prevalence of poor biological response to clopidogrel', and 'A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin'.
h-index
citations
850
works
20
NIH funding
primary concept
email

Recent publications

Tyrosine kinase inhibitors and direct oral anticoagulants: In vitro evaluation of drug–drug interaction mediated by P‐glycoprotein
Fundamental and Clinical Pharmacology 2022cited by 19position: lastdoi
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Clinical Infectious Diseases 2020cited by 94position: lastdoi
Exposure–Response Relationship of Tranexamic Acid in Cardiac Surgery
Anesthesiology 2020cited by 59position: middledoi
A new paradigm for personalized prophylaxis for patients with severe haemophilia A
Haemophilia 2020cited by 26position: firstdoi
Pharmacokinetics for haemophilia treaters: Meaning of PK parameters, interpretation pitfalls, and use in the clinic
Thrombosis Research 2020cited by 20position: firstdoi
Pharmacological characterization of the 3D MucilAir™ nasal model
European Journal of Pharmaceutics and Biopharmaceutics 2019cited by 55position: lastdoi
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants
Thrombosis Research 2019cited by 39position: middledoi
Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin/PAR-1 pathway
Brain Research 2019cited by 26position: middledoi
In vitro assessment of P‐gp and BCRP transporter‐mediated drug–drug interactions of riociguat with direct oral anticoagulants
Fundamental and Clinical Pharmacology 2019cited by 22position: lastdoi
Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies
International Journal of Pharmaceutics 2018cited by 52position: middledoi
Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs
Molecular Pharmaceutics 2018cited by 30position: lastdoi
In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition
European Journal of Drug Metabolism and Pharmacokinetics 2017cited by 52position: lastdoi
Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty
Anesthesiology 2017cited by 43position: middledoi
Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
European Journal of Drug Metabolism and Pharmacokinetics 2017cited by 34position: lastdoi
Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass
British Journal of Anaesthesia 2017cited by 28position: firstdoi
Effect of Activated Charcoal on Rivaroxaban Complex Absorption
Clinical Pharmacokinetics 2016cited by 38position: lastdoi
In vitro and in vivo evaluation of drug–drug interaction between dabigatran and proton pump inhibitors
Fundamental and Clinical Pharmacology 2015cited by 35position: lastdoi
Investigation of drug–drug interactions between clopidogrel and fluoxetine
Fundamental and Clinical Pharmacology 2013cited by 28position: firstdoi
Prevalence of poor biological response to clopidogrel
Thrombosis and Haemostasis 2012cited by 81position: middledoi
A semi‐mechanistic absorption model to evaluate drug–drug interaction with dabigatran: application with clarithromycin
British Journal of Clinical Pharmacology 2012cited by 69position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Sophie Hodin · Université Claude Bernard Lyon 19 papers (2015–2022)Édouard Ollier · Université Claude Bernard Lyon 16 papers (2012–2020)Patrick Mismetti · Université Claude Bernard Lyon 16 papers (2012–2017)Nathalie Perek · Université Claude Bernard Lyon 16 papers (2017–2019)Laurent Bertoletti · Centre Georges François Leclerc5 papers (2012–2022)Thierry Basset · Université Claude Bernard Lyon 15 papers (2012–2017)Clément Mercier · Université Claude Bernard Lyon 14 papers (2017–2019)Zhiguo Hé · Université Claude Bernard Lyon 14 papers (2018–2019)Julien Lanoiselée · Université Claude Bernard Lyon 14 papers (2016–2020)Patrick Mismetti · Université Claude Bernard Lyon 13 papers (2017–2019)Silvy Laporte · Université Claude Bernard Lyon 13 papers (2012–2013)Elodie Jacqueroux · Université Claude Bernard Lyon 13 papers (2017–2019)Paul Zufferey · Université Claude Bernard Lyon 13 papers (2012–2020)Sandrine Accassat · Centre Hospitalier Universitaire de Saint-Étienne3 papers (2012–2016)Nora Mallouk · Université Claude Bernard Lyon 12 papers (2012–2013)Michèle Piot · Université Claude Bernard Lyon 12 papers (2012–2013)Valérie Forest · Université Claude Bernard Lyon 12 papers (2018–2019)Yesim Dargaud · Université Claude Bernard Lyon 12 papers (2020–2020)Arnauld Garcin · Université Claude Bernard Lyon 12 papers (2012–2013)Clémentine Puech · Université Claude Bernard Lyon 12 papers (2018–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cardiology and Cardiovascular Medicine · Internal Medicine →